Detailed Narrative
Aflac Japan's Strategic Product and Distribution Focus
Aflac Japan achieved a 5.6% sales increase for FY24 and a 9% increase in Q4, driven by the Tsumitasu product launched in June 2024. Management emphasized Tsumitasu's appeal to younger customers and its role as a 'hook product' to drive third-sector sales, particularly medical and cancer policies. A new cancer insurance product, 'WINGS,' is planned for a staged launch between March and April, featuring enhanced protection and flexible coverage, including a new plan for children. The company continues to optimize its broad distribution network, including agencies, alliance partners, and banks, to reach Japanese consumers.
Aflac U.S. Sales Challenges and Recovery Efforts
Aflac U.S. experienced a 1% sales decline for FY24, with Q4 sales lower than expected, notably a 33% decline in dental sales. This was attributed to a combination of stronger underwriting discipline, which prioritizes profitable growth, and the need to re-engage agents and brokers following a prior system implementation issue with the network dental operation. Management expressed confidence in the recovered dental platform and expects increased sales in 2025, alongside strong performance in group life and disability, and direct-to-consumer channels.
Capital Deployment and Shareholder Returns
Aflac demonstrated a strong commitment to shareholder returns, deploying $3.9 billion in capital in 2024. This included $2.8 billion for share repurchases, with $750 million executed in Q4, marking the largest single-quarter repurchase. The company also maintained its track record of 42 consecutive years of dividend growth. Management highlighted the strong capital position, with SMR above 1,150%, ESR around 270%, and combined RBC estimated at over 650%, supporting both organic growth investments and capital returns.
Commercial Real Estate Portfolio Management
The company continues to manage through a challenging commercial real estate market, increasing CECL reserves by $40 million in Q4 due to distressed valuations. Two loans were foreclosed and added to the real estate-owned portfolio. Management believes the current market does not reflect the intrinsic value of its portfolio and is confident in its ability to manage these assets through the cycle to maximize recoveries. The outlook for 2025 anticipates a similar environment to 2024, with a long recovery expected.
Impact of Interest Rates on Net Investment Income
Net investment income is expected to face headwinds in 2025, particularly from the floating rate portfolio in Japan and cash holdings in the Corporate segment. Anticipated rate cuts in 2025, following a 100 basis point decline in SOFR in 2024, will lead to lower floating rate income. An existing interest rate swap, designed as a tail hedge, is currently out-of-the-money and ineffective, meaning small declines in short-term interest rates will directly impact net investment income. This is a primary factor in the lower end of the pretax margin guidance for Japan.
Reinsurance Strategy and Capital Efficiency
Aflac has ceded approximately 6% of its Aflac Japan asset base to Aflac Re Bermuda, well within its internal 10% cap. This strategy has improved balance sheet efficiency, enhanced return on equity, and reduced risk for Aflac Japan operations. Management is pleased with the outcomes and will reassess the internal cap as it approaches the 10% level, particularly in light of the ongoing transition to the ESR capital regime framework in Japan, expected to be fully implemented by Q1 2026.